GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Glaukos Corp (STU:6GJ) » Definitions » Cyclically Adjusted PB Ratio

Glaukos (STU:6GJ) Cyclically Adjusted PB Ratio : 13.45 (As of Jun. 23, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Glaukos Cyclically Adjusted PB Ratio?

As of today (2024-06-23), Glaukos's current share price is €104.00. Glaukos's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €7.73. Glaukos's Cyclically Adjusted PB Ratio for today is 13.45.

The historical rank and industry rank for Glaukos's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:6GJ' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 7.7   Med: 10.5   Max: 13.12
Current: 13.02

During the past years, Glaukos's highest Cyclically Adjusted PB Ratio was 13.12. The lowest was 7.70. And the median was 10.50.

STU:6GJ's Cyclically Adjusted PB Ratio is ranked worse than
94.98% of 478 companies
in the Medical Devices & Instruments industry
Industry Median: 2.03 vs STU:6GJ: 13.02

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Glaukos's adjusted book value per share data for the three months ended in Mar. 2024 was €8.319. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €7.73 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Glaukos Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Glaukos's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glaukos Cyclically Adjusted PB Ratio Chart

Glaukos Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 9.33

Glaukos Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 9.57 9.33 10.86

Competitive Comparison of Glaukos's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Glaukos's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glaukos's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Glaukos's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Glaukos's Cyclically Adjusted PB Ratio falls into.



Glaukos Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Glaukos's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=104.00/7.73
=13.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Glaukos's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Glaukos's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=8.319/131.7762*131.7762
=8.319

Current CPI (Mar. 2024) = 131.7762.

Glaukos Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 -4.131 99.070 -5.495
201503 0.191 99.621 0.253
201506 2.644 100.684 3.460
201509 2.631 100.392 3.454
201512 2.715 99.792 3.585
201603 2.720 100.470 3.568
201606 2.843 101.688 3.684
201609 2.948 101.861 3.814
201612 3.275 101.863 4.237
201703 3.354 102.862 4.297
201706 3.255 103.349 4.150
201709 3.208 104.136 4.059
201712 3.373 104.011 4.273
201803 3.331 105.290 4.169
201806 3.618 106.317 4.484
201809 3.894 106.507 4.818
201812 4.233 105.998 5.262
201903 4.518 107.251 5.551
201906 4.536 108.070 5.531
201909 4.676 108.329 5.688
201912 13.929 108.420 16.930
202003 13.163 108.902 15.928
202006 13.204 108.767 15.997
202009 12.530 109.815 15.036
202012 12.126 109.897 14.540
202103 10.773 111.754 12.703
202106 10.437 114.631 11.998
202109 10.902 115.734 12.413
202112 11.064 117.630 12.395
202203 11.523 121.301 12.518
202206 11.221 125.017 11.828
202209 11.624 125.227 12.232
202212 10.477 125.222 11.025
202303 9.907 127.348 10.252
202306 9.325 128.729 9.546
202309 9.186 129.860 9.322
202312 8.621 129.419 8.778
202403 8.319 131.776 8.319

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Glaukos  (STU:6GJ) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Glaukos Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Glaukos's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Glaukos (STU:6GJ) Business Description

Traded in Other Exchanges
Address
One Glaukos Way, Aliso Viejo, CA, USA, 92656
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Glaukos (STU:6GJ) Headlines

No Headlines